Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Nortech Systems Incorporated
Nortech Systems Reports Third Quarter Results
Business
Nov 13 2025
12 min read

Nortech Systems Reports Third Quarter Results

news images

MINNEAPOLIS, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Nortech Systems Incorporated (Nasdaq: NSYS) (“Nortech” or the “Company”), a leading provider of engineering and manufacturing solutions for complex electromedical and electromechanical products serving the medical imaging, medical device, industrial, and aerospace & defense markets, reported financial results for the third quarter ended September 30, 2025.

2025 Q3 Highlights:

 

Net sales of $30.5 million in Q3 2025 vs. $31.4 million in Q3 2024

 

Net loss of $(146) thousand, or $(0.05) per basic share in Q3 2025 vs. $(739) thousand, or $(0.27) per basic share in Q3 2024

 

Adjusted earnings before interest, taxes, depreciation, and amortization (“EBITDA”) of $1.3 million in Q3 2025 vs. $0.1 million in Q3 2024

 

90-day backlog of $31.3 million as of September 30, 2025 vs. $29.6 million as of September 30, 2024

 

 

 

Management Commentary

“Nortech’s third quarter results reflect continued evidence our restructuring efforts combined with cost discipline are paying off. A planned positive shift from first builds to recurring production across programs transferred between our plants is due to increased manufacturing efficiencies. I am very proud of the entire team’s execution and focus to achieve our goals,” said President & CEO, Jay D. Miller.

“Further, we recently completed a significant regulatory milestone with our Monterrey, Mexico facility achieving AS9100:D certification.” Miller added, “This certification underscores Nortech’s capability to deliver complex, high-reliability products for demanding applications, enhancing our service offerings to both current and prospective clients in the aerospace and industrial markets. This achievement further supports our viewpoint that we are well positioned to continue to leverage our operational performance in the current nearshoring landscape with our North American and Asian footprint,” Miller said.

Summary Financial Information

The following table provides summary financial information comparing the third quarter 2025 (“Q3 2025”) financial results to the same quarter in 2024 (“Q3 2024”) as well as the nine-month period ended September 30, 2025 (“YTD 2025”) with the same period in 2024 (“YTD 2024”).

($ in thousands)

 

Q3 2025

 

 

Q3 2024

 

 

% Change

 

 

YTD 2025

 

 

YTD 2024

 

 

% Change

 

Net sales

 

$

30,482

 

 

$

31,407

 

 

 

(2.9

)%

 

$

88,052

 

 

$

99,513

 

 

 

(11.5

)%

Gross profit

 

$

5,025

 

 

$

3,835

 

 

 

31.0

%

 

$

12,940

 

 

$

13,900

 

 

 

(6.9

)%

Operating expenses

 

$

4,080

 

 

$

4,302

 

 

 

(5.2

)%

 

$

12,866

 

 

$

12,868

 

 

 

0.0

%

Net (loss) income

 

$

(146

)

 

$

(739

)

 

 

80.2

%

 

$

(1,149

)

 

$

183

 

 

 

(727.9

)%

EBITDA

 

$

1,253

 

 

$

(33

)

 

 

3,897

%

 

$

1,060

 

 

$

2,432

 

 

 

(56.4

)%

Adjusted EBITDA

 

$

1,253

 

 

$

143

 

 

 

776.2

%

 

$

1,326

 

 

$

2,699

 

 

 

(50.9

)%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Conference Call

The Company will hold a live conference call and webcast at 3:30 p.m. central time on Thursday, November 13, to discuss the Company’s 2025 third quarter results. The call will be hosted by Jay D. Miller, Chief Executive Officer and President and Andrew D. C. LaFrence, Chief Financial Officer. To access the live audio conference call, US participants may call 888-506-0062 and international participants may call 973-528-0011. Participant Access Code: 107099. Participants may also access the call via webcast at: https://www.webcaster4.com/Webcast/Page/2814/52858.

###

About Nortech Systems Incorporated

Nortech Systems is a leading provider of design and manufacturing solutions for complex electromedical devices, electromechanical systems, assemblies, and components. Nortech primarily serves the medical imaging, medical device, aerospace & defense, and industrial markets. Its design services span concept development to commercial design, and include medical device, software, electrical, mechanical, and biomedical engineering. Its manufacturing and supply chain capabilities are vertically integrated around wire, cable, and interconnect assemblies, printed circuit board assemblies, as well as system-level assembly, integration, and final test. Headquartered in Maple Grove, Minn., Nortech currently has six manufacturing locations and design centers across the U.S., Latin America, and Asia. Nortech Systems is traded on the NASDAQ Stock Market under the symbol NSYS. Nortech’s website is www.nortechsys.com.

Forward-Looking Statements

This press release contains forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995 including without limitation statements regarding future financial results, our ability to generate positive EBITDA, increased plant utilization, growth of our backlog, gaining approval of customers relating to moving production from one facility to another Company-owned facility, improving logistics, nearshoring as a strategic advantage Mexico holds in today’s tariff environment, effect of our intellectual property on financial performance, financial impact of shifting production focus from copper to fiber over time, effects of restructuring and consolidating manufacturing facilities, sustained long-term health and growth, and optimism about customer pipeline. While this release is based on management’s best judgment and current expectations, actual results may differ materially from those expressed or implied and involve a number of risks and uncertainties. Important factors that could cause actual results to differ materially from the forward-looking statements include, without limitation: (1) commodity cost increases coupled with challenges in raising prices and/or customer pressure to reduce prices; (2) supply chain disruptions leading to shortages of critical components; (3) volatility in market conditions which may affect demand for the Company’s products; (4) increased competition and/or reduced demand; (5) changes in the reliability and efficiency of operating facilities or those of third parties; (6) risks related to the availability of labor; (7) the unanticipated loss of any key member of senior management; (8) geopolitical, economic, financial and business conditions including changing tariff environment; (9) the Company’s ability to steadily improve manufacturing output and product quality; (10) the impact of global health epidemics on our customers, employees, manufacturing facilities, suppliers, the capital markets and our financial condition; (11) challenges with customers with respect to moving production from one facility to another Company-owned facility or (12) financing cost increases and continued availability. Some of the above-mentioned factors are described in further detail in the section entitled “Risk Factors” in our annual and quarterly reports, as applicable. You should assume the information appearing in this document is accurate only as of the date hereof, or as otherwise specified, as our business, financial condition, results of operations and prospects may have changed since such date. Except as required by applicable law, including the securities laws of the United States and the rules and regulations of the United States Securities and Exchange Commission, we undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, to reflect actual results or changes in factors or assumptions affecting such forward-looking statements.

Reconciliation of Generally Accepted Accounting Principles (“GAAP”) Measures to Non-GAAP Financial Measure

EBITDA is a non-GAAP financial measure used by management that we believe provides useful information to investors because it reflects ongoing performance excluding certain non-recurring items during comparable periods and facilitates comparisons between peer companies since interest, taxes, depreciation, and amortization can differ greatly between different organizations as a result of differing capital structures and tax strategies. EBITDA is defined as net income (loss) plus interest expense, plus income tax expense plus depreciation expense and amortization expense. EBITDA should be considered in addition to, not as a substitute for, or superior to, financial measures calculated in accordance with GAAP. Adjusted EBITDA reflects the impact of restructuring and non-recurring items. EBITDA and Adjusted EBITDA are not a measurement of our financial performance under GAAP and should not be considered an alternative to net sales or net income (loss), as applicable, or any other performance measures derived in accordance with GAAP and may not be comparable to other similarly titled measures of other businesses. EBITDA and Adjusted EBITDA have limitations as an analytical metric, and you should not consider it in isolation or as a substitute for analysis of our operating results as reported under GAAP.

NORTECH SYSTEMS INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
AND COMPREHENSIVE (LOSS) INCOME
(UNAUDITED)
(IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA)

 

 

THREE MONTHS ENDED

 

 

NINE MONTHS ENDED

 

 

 

SEPTEMBER 30,

 

 

SEPTEMBER 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

30,482

 

 

$

31,407

 

 

$

88,052

 

 

$

99,513

 

Cost of goods sold

 

 

25,457

 

 

 

27,572

 

 

 

75,112

 

 

 

85,613

 

Gross profit

 

 

5,025

 

 

 

3,835

 

 

 

12,940

 

 

 

13,900

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling

 

 

1,221

 

 

 

891

 

 

 

3,609

 

 

 

2,605

 

General and administrative

 

 

2,593

 

 

 

2,951

 

 

 

8,097

 

 

 

9,103

 

Research and development

 

 

266

 

 

 

284

 

 

 

894

 

 

 

893

 

Restructuring charges

 

 

-

 

 

 

176

 

 

 

266

 

 

 

267

 

Total operating expenses

 

 

4,080

 

 

 

4,302

 

 

 

12,866

 

 

 

12,868

 

Income (loss) from operations

 

 

945

 

 

 

(467

)

 

 

74

 

 

 

1,032

 

Other expense:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

 

(273

)

 

 

(216

)

 

 

(744

)

 

 

(548

)

Income (loss) before income taxes

 

 

672

 

 

 

(683

)

 

 

(670

)

 

 

484

 

Income tax expense

 

 

818

 

 

 

56

 

 

 

479

 

 

 

301

 

Net (loss) income

 

$

(146

)

 

$

(739

)

 

$

(1,149

)

 

$

183

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income per common share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic (in dollars per share)

 

$

(0.05

)

 

$

(0.27

)

 

$

(0.41

)

 

$

0.07

 

Weighted average number of common shares outstanding - basic (in shares)

 

 

2,785,541

 

 

 

2,760,438

 

 

 

2,773,401

 

 

 

2,754,389

 

Diluted (in dollars per share)

 

$

(0.05

)

 

$

(0.27

)

 

$

(0.41

)

 

$

0.06

 

Weighted average number of common shares outstanding - diluted (in shares)

 

 

2,785,541

 

 

 

2,760,438

 

 

 

2,773,401

 

 

 

2,931,343

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other comprehensive (loss) income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation

 

 

(21

)

 

 

223

 

 

 

109

 

 

 

(135

)

Comprehensive (loss) income, net of tax

 

$

(167

)

 

$

(516

)

 

$

(1,040

)

 

$

48

 


NORTECH SYSTEMS INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS
AS OF SEPTEMBER 30, 2025 AND DECEMBER 31, 2024
(UNAUDITED)
(IN THOUSANDS, EXCEPT SHARE DATA)

 

 

SEPTEMBER 30, 2025

 

 

DECEMBER 31, 2024

 

ASSETS

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

Cash

 

$

1,271

 

 

$

916

 

Accounts receivable, less allowances of $186 and $196, respectively

 

 

18,810

 

 

 

14,875

 

Inventories, net

 

 

18,425

 

 

 

21,638

 

Contract assets

 

 

15,328

 

 

 

13,792

 

Prepaid assets and other assets

 

 

5,372

 

 

 

4,094

 

Total current assets

 

 

59,206

 

 

 

55,315

 

Property and equipment, net

 

 

5,322

 

 

 

6,232

 

Operating lease assets, net

 

 

7,306

 

 

 

8,139

 

Deferred tax assets

 

 

2,763

 

 

 

2,575

 

Other intangible assets, net

 

 

160

 

 

 

174

 

Total assets

 

$

74,757

 

 

$

72,435

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Line of credit

 

$

12,030

 

 

$

-

 

Accounts payable

 

 

11,678

 

 

 

11,582

 

Accrued payroll and commissions

 

 

2,402

 

 

 

1,841

 

Customer deposits

 

 

4,716

 

 

 

5,140

 

Current portion of operating lease obligations

 

 

1,319

 

 

 

1,175

 

Current portion of finance lease obligations

 

 

239

 

 

 

143

 

Notes payable

 

 

-

 

 

 

344

 

Other accrued liabilities

 

 

1,221

 

 

 

1,203

 

Total current liabilities

 

 

33,605

 

 

 

21,428

 

Long-term liabilities:

 

 

 

 

 

 

 

 

Long-term line of credit

 

 

-

 

 

 

8,634

 

Long-term operating lease obligations, net of current portion

 

 

6,795

 

 

 

7,773

 

Long-term finance lease obligations, net of current portion

 

 

713

 

 

 

311

 

Other long-term liabilities

 

 

287

 

 

 

284

 

Total long-term liabilities

 

 

7,795

 

 

 

17,002

 

Total liabilities

 

 

41,400

 

 

 

38,430

 

Shareholders’ equity:

 

 

 

 

 

 

 

 

Preferred stock, $1 par value; 1,000,000 shares authorized; 250,000 shares issued and outstanding

 

 

250

 

 

 

250

 

Common stock - $0.01 par value; 9,000,000 shares authorized; 2,786,134 and 2,760,793 shares issued and outstanding, respectively

 

 

28

 

 

 

28

 

Additional paid-in capital

 

 

17,721

 

 

 

17,329

 

Accumulated other comprehensive loss

 

 

(868

)

 

 

(977

)

Retained earnings

 

 

16,226

 

 

 

17,375

 

Total shareholders’ equity

 

 

33,357

 

 

 

34,005

 

Total liabilities and shareholders’ equity

 

$

74,757

 

 

$

72,435

 


NORTECH SYSTEMS INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
(IN THOUSANDS)

 

 

NINE MONTHS ENDED SEPTEMBER 30,

 

 

 

2025

 

 

2024

 

CASH FLOWS FROM OPERATING ACTIVITIES

 

 

 

 

 

 

 

 

Net (loss) income

 

$

(1,149

)

 

$

183

 

Adjustments to reconcile net (loss) income to net cash used in operating activities:

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

986

 

 

 

1,400

 

Compensation on stock-based awards

 

 

369

 

 

 

334

 

Deferred income taxes

 

 

(189

)

 

 

-

 

Change in accounts receivable allowance

 

 

(10

)

 

 

(72

)

Change in inventory reserves

 

 

346

 

 

 

194

 

Other, net

 

 

-

 

 

 

9

 

Changes in current operating assets and liabilities:

 

 

 

 

 

 

 

 

Accounts receivable

 

 

(3,875

)

 

 

2,727

 

Inventories

 

 

2,823

 

 

 

(922

)

Contract assets

 

 

(1,536

)

 

 

(577

)

Prepaid expenses and other assets

 

 

(1,244

)

 

 

(2,888

)

Accounts payable

 

 

165

 

 

 

(3,609

)

Accrued payroll and commissions

 

 

555

 

 

 

(1,198

)

Customer deposits

 

 

(424

)

 

 

1,195

 

Other accrued liabilities

 

 

318

 

 

 

181

 

Net cash used in operating activities

 

 

(2,865

)

 

 

(3,043

)

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES

 

 

 

 

 

 

 

 

Proceeds from sale of property and equipment

 

 

504

 

 

 

9

 

Purchases of equipment

 

 

(517

)

 

 

(980

)

Net cash used in investing activities

 

 

(13

)

 

 

(971

)

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES

 

 

 

 

 

 

 

 

Proceeds from line of credit

 

 

76,215

 

 

 

99,888

 

Payments to line of credit

 

 

(72,880

)

 

 

(96,185

)

Proceeds from financing leases

 

 

-

 

 

 

198

 

Principal payments on financing leases

 

 

(140

)

 

 

(304

)

Share repurchases

 

 

-

 

 

 

(67

)

Stock option exercises

 

 

23

 

 

 

31

 

Net cash provided by financing activities

 

 

3,218

 

 

 

3,561

 

 

 

 

 

 

 

 

 

 

Effect of exchange rate changes on cash

 

 

15

 

 

 

17

 

 

 

 

 

 

 

 

 

 

Net change in cash

 

 

355

 

 

 

(436

)

Cash - beginning of period

 

 

916

 

 

 

1,675

 

Cash - end of period

 

$

1,271

 

 

$

1,239

 


RECONCILIATION OF NET (LOSS) INCOME TO EBITDA AND ADJUSTED EBITDA

 

 

THREE MONTHS ENDED
SEPTEMBER 30,

 

 

NINE MONTHS ENDED
SEPTEMBER 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

 

 

 

 

 

 

 

 

 

 

 

 

 

($ in thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income

 

$

(146

)

 

$

(739

)

 

$

(1,149

)

 

$

183

 

Interest

 

 

273

 

 

 

216

 

 

 

744

 

 

 

548

 

Taxes

 

 

818

 

 

 

56

 

 

 

479

 

 

 

301

 

Depreciation

 

 

303

 

 

 

430

 

 

 

972

 

 

 

1,316

 

Amortization

 

 

5

 

 

 

4

 

 

 

14

 

 

 

84

 

EBITDA

 

 

1,253

 

 

 

(33

)

 

 

1,060

 

 

 

2,432

 

Restructuring charges

 

 

-

 

 

 

176

 

 

 

266

 

 

 

267

 

ADJUSTED EBITDA

 

$

1,253

 

 

$

143

 

 

$

1,326

 

 

$

2,699

 


There were no material adjustments to EBITDA in the quarter ended September 30, 2025. Adjustment to EBITDA in the nine months ended September 30, 2025 includes ($ in thousands):

 

During the first quarter of 2025, we incurred $235 of severance charges for a February 2025 reduction in force to align staffing to our forecasted net sales and $31 of expenses related to our closed Blue Earth facility, which expense amount is not included in Adjusted EBITDA.

 

 

 

Adjustment to EBITDA in 2024 includes ($ in thousands):

 

In connection with the Blue Earth facility closure, we accrued $176 and $267 of retention bonus and other expenses in the three and nine-months ended September 30, 2024, respectively, which expense amount is not included in Adjusted EBITDA.


($ in millions)

 

Last Twelve Months (“LTM”) Ended in Quarter

 

 

 

Q3 2022

 

 

Q4 2022

 

 

Q1 2023

 

 

Q2 2023

 

 

Q3 2023

 

 

Q4 2023

 

 

Q1 2024

 

 

Q2 2024

 

 

Q3 2024

 

 

Q4 2024

 

 

Q1 2025

 

 

Q2 2025

 

 

Q3 2025

 

Net Sales

 

$

132.0

 

 

$

134.1

 

 

$

138.3

 

 

$

140.8

 

 

$

138.9

 

 

$

139.3

 

 

$

138.7

 

 

$

137.5

 

 

$

135.6

 

 

$

128.1

 

 

$

120.8

 

 

$

117.6

 

 

$

116.7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross Profit $ - Adjusted

 

 

18.1

 

 

 

20.5

 

 

 

21.9

 

 

 

22.4

 

 

 

21.4

 

 

 

23.1

 

 

 

23.1

 

 

 

22.2

 

 

 

20.7

 

 

 

16.7

 

 

 

14.4

 

 

 

14.6

 

 

 

15.8

 

Gross Margin % - Adjusted

 

 

13,7

%

 

 

15.3

%

 

 

15.8

%

 

 

15.9

%

 

 

15.4

%

 

 

16.6

%

 

 

16.6

%

 

 

16.1

%

 

 

14.9

%

 

 

13.1

%

 

 

11.9

%

 

 

12.4

%

 

 

13.5

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBITDA - Adjusted

 

$

4.2

 

 

$

5.8

 

 

$

6.7

 

 

$

6.8

 

 

$

6.0

 

 

$

8.0

 

 

$

8.1

 

 

$

7.3

 

 

$

5.9

 

 

$

2.1

 

 

$

(0.5

)

 

$

(0.4

)

 

$

0.7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contact

Andrew D. C. LaFrence
Chief Financial Officer and Senior Vice President of Finance
[email protected]
952-345-2243